SCHEMBL7592572

SCHEMBL7592572

COC(=O)Cc1cn(C)c2cc(-n3ccnc3)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.46
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CYP3A4 P08684 1/20 0.40
BAZ2B Q9UIF8 1/20 0.40
MAPT P10636 4/20 0.40
LMNA P02545 4/20 0.40
MAPK8 P45983 1/20 0.39
MAPK10 P53779 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ADH5 P11766 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
MITF O75030 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 1/20 0.37
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7526498 0.86 CYP3A4 (0.42) HTTCYP11B1CYP11B2CYP3A4BAZ2B
SCHEMBL27814145 0.79 HTT (0.52) HTTCYP11B1CYP11B2CYP3A4BAZ2B
SCHEMBL7524516 0.77 MAPT (0.44) HTTMAPTLMNAALDH1A1KDM4E
SCHEMBL2085331 0.76 KDM4E (0.51) MAPTLMNAALDH1A1KDM4EMEN1
SCHEMBL14564357 0.76 ICMT (0.47) HTTMAPTLMNAALDH1A1KDM4E
SCHEMBL5447791 0.74 KDM4E (0.44) MAPTLMNAALDH1A1KDM4EMEN1
SCHEMBL28836368 0.74 MEN1 (0.50) MAPTLMNAALDH1A1KDM4EMEN1
SCHEMBL7593302 0.74 CYP3A4 (0.44) HTTCYP11B1CYP11B2CYP3A4BAZ2B
SCHEMBL7591435 0.74 MAPT (0.49) HTTMAPTLMNAALDH1A1KDM4E
SCHEMBL31498840 0.71 KDM4E (0.65) MAPTLMNAALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242409-A2 SUBSTITUTED BISINDOLYLMALEIMIDES F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2001046178-A2 SUBSTITUIERTE BISINDOLYMALEIMIDE F. HOFFMANN-LA ROCHE AG (CH) 2001-06-28 WO disclosed